Cao Sean Wuxiong
Cao Sean Wuxiong, CBDO, reported an open-market or private sale at NovaBridge Biosciences involving 107978.000000 shares for an estimated $79903.72. Reported holdings after the transaction were 266467.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Sep 09, 2026
- Filing date
- Sep 11, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 374,445 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
NBP price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0002109966-26-000008 Ordinary Shares
- Transaction date
- Sep 09, 2026 Filed Sep 11, 2026, 08:30 PM · 2d delay
- Shares
- 107,978 sh $0.74 per share
- Estimated value
- -$79.9k Computed from shares × price
- Holdings after
- 266,467 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Bus. Development Officer
- F1
The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer.
- F2
The Reporting Person sold 46,947 ADSs representing approximately 107,978 ordinary shares in connection with the partial vesting of a restricted stock unit award on September 3, 2026, solely to satisfy…
- F3
Reported securities are represented by 46,947 ADSs.
- F4
Reported sales price represents the converted sales price of the ADSs of $1.6908.
0 other transactions
0 recent txs